Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2012
06/21/2012US20120157531 Compositions and methods for lowering triglycerides
06/21/2012US20120157530 Methods of treating hypertriglyceridemia
06/21/2012US20120157516 Novel thiophene compounds for use in therapy
06/21/2012US20120157513 Small Peptide Expression System in Mammalian Cells
06/21/2012US20120157504 New Process
06/21/2012US20120157503 Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
06/21/2012US20120157469 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157460 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157459 Novel 3-hydroxy-5-arylisothiazole derivative
06/21/2012US20120157437 Vla-4 inhibitory drug
06/21/2012US20120157425 New compounds, pharmaceutical compositions and uses thereof
06/21/2012US20120157420 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
06/21/2012US20120157415 New Crystalline Form of Pemirolast
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157409 Appetite suppressant product and method
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157398 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
06/21/2012US20120157397 Trimethylamine-containing compounds for diagnosis and prediction of disease
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157384 Mutants pf4 polypeptides exhibiting an increased anti-angiogenic activity
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157382 Pharmaceutical glp-1 compositions having an improved release profile
06/21/2012US20120157380 Pegylated human apoa-1 and process for production thereof
06/21/2012US20120157379 Gastric Inhibitory Peptide Variants and Their Uses
06/21/2012US20120157378 Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes
06/21/2012US20120156314 11 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS
06/21/2012US20120156296 Antioxidants in fish oil powder and tablets
06/21/2012US20120156285 Methods of treating hypertriglyceridemia
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156207 Methods and compositions for inhibiting cd32b expressing cells
06/21/2012US20120156204 Methods for increasing adiponectin
06/21/2012US20120156201 Humanized antibodies specific for hsp65-derived peptide-6 methods and uses thereof
06/21/2012US20120156185 Nutritional compositions comprising citrus fibers
06/21/2012US20120156183 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
06/21/2012US20120156181 Therapeutic agent for liver-related diseases
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012CA2821900A1 Continuous arycyclic compound
06/21/2012CA2821886A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/21/2012CA2821613A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012CA2821219A1 Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
06/21/2012CA2787154A1 A compound sea cucumber preparation and manufacturing method thereof
06/20/2012EP2465938A1 Production method for astaxanthin-containing composition
06/20/2012EP2465847A1 Azetidinone compounds and medical use thereof
06/20/2012EP2465542A1 Oligosaccharide-protein conjugates
06/20/2012EP2465517A1 Composition based on extra virgin olive oils
06/20/2012EP2464626A1 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid
06/20/2012EP2464333A2 Floating microgranules
06/20/2012EP2464228A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2172195B1 Cholesterol-control agent
06/20/2012EP2152707B1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
06/20/2012EP2021321B1 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
06/20/2012EP2012773B1 Drugs and uses
06/20/2012CN1750758B Compounds for the treatment of metabolic disorders
06/20/2012CN102510867A Glycoside derivative and uses thereof
06/20/2012CN102510865A Nitrogen-containing spiro-ring compound and medicinal use of same
06/20/2012CN102505006A Modulation of stem and progenitor cell differentiation, assays, and uses thereof
06/20/2012CN102504046A Amphipathy polyethylene glycol stem grafting chitosan copolymer and preparation method and application thereof
06/20/2012CN102504039A Extraction process of black corn silk polysaccharide
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504006A Steroid saponin compound in siberian fritillary bulb
06/20/2012CN102504005A Compound with novel structure and preparation method and applications thereof
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503932A Novel gas signal molecule donator and preparation method and use thereof
06/20/2012CN102503899A Crystal of phenylalanine derivative, process for producing the same and use thereof
06/20/2012CN102503894A 5-substituted methylene imidazolidine-2, 4-diketone derivative as well as pharmaceutical composition and application thereof
06/20/2012CN102503891A Pyrazole derivatives as 11-beta-hsd1 inhibitors
06/20/2012CN102503798A Method for extracting coenzyme Q 10 from bee pollen and application thereof
06/20/2012CN102499968A Drug for treating diabetes and preparation method thereof
06/20/2012CN102499940A Medicine for promoting chickens to grow healthily and quickly
06/20/2012CN102499939A Pharmaceutical compositions of fat-soluble vitamins for injection and water-soluble vitamins for injection and preparation method thereof
06/20/2012CN102499930A Medicinal fructose composition and preparation method thereof
06/20/2012CN102499929A 42-(Dimethylphosphinate)rapamycin solid composition and coating method thereof
06/20/2012CN102499905A Controllable photoresponse type hydrophobic medicament carrier hydrogel and preparation method thereof
06/20/2012CN102499379A Preparation technology for compound aquatic organism collagen peptide-calcium complex, technology for preparing calcium supplement from complex, and application of calcium supplement
06/20/2012CN102499299A Solid instant Puerh tea for reducing fat and losing weight and preparation process thereof
06/20/2012CN102028715B Method for extracting total flavonoids from plants
06/20/2012CN102018950B Drug for treating hypertension
06/20/2012CN101935656B Gene for promoting insulin secretion, preparation method and application thereof
06/20/2012CN101890035B Application of trifolin
06/20/2012CN101874818B Medicament or health-care product composition for reducing blood pressure or blood fat and preparation method and application thereof
06/20/2012CN101829272B Traditional Chinese medicine composition for treating diabetes mellitus and preparation method thereof
06/20/2012CN101804170B Traditional Chinese medicine composition for treating hyperglycemia and preparation method thereof
06/20/2012CN101670010B Method for extracting flavonoid glycoside substance
06/20/2012CN101554410B Detection method of fresh fleece flower root and prepared fleece flower root
06/20/2012CN101531904B Bamboo leaves extract, preparing method and purpose thereof
06/20/2012CN101491495B Salvianolic acid B magnesium injection, preparation method and use thereof
06/20/2012CA2726085A1 User of marihuana and compounds therein for treating obesity
06/19/2012US8202906 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy
06/19/2012US8202878 Type 2 diabetes, obesity, elevated plasma triglycerides, metabolic syndrome, non-alcoholic steatohepatitis, and non-alcoholic fatty liver disease;Trans [4-(4-{3-[2-(1-adamantyl)-2-hydroxyethoxy]-1H-pyrazol-5-yl}phenyl)cyclohexyl]acetic acid
06/19/2012US8202857 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1
06/19/2012US8202856 Triazole oxadiazoles derivatives
06/19/2012US8202513 Aryl potassium channel blockers and uses thereof
06/19/2012CA2648985C Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity
06/19/2012CA2559302C 6-amino-1h-pyrimidine-2,4-dione derivatives as dipeptidyl peptidase inhibitors
06/19/2012CA2512563C Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
1 ... 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 ... 1298